Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Christgen

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
BMC Biotechnology|November 29, 2008
Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technologyBritta Hasemeier, Matthias Christgen, Hans Kreipe, et al.
International Journal of Cancer|March 15, 2021
Transcription factor AP-2beta in development, differentiation and tumorigenesisMieke Raap, Lisa Gierendt, Hans H Kreipe, et al.
Cancer Letters|August 23, 2005
Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cellsMatthias Christgen, Bodo Schniewind, Astrid Jueschke, et al.
Pathology, Research and Practice|January 26, 2024
Malignant phyllodes tumor and invasive lobular breast carcinoma: Morpho-molecular characterization of an uncommon collision tumor and review of the literatureNora Schaumann, Stephan Bartels, Elna Kuehnle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Recognition and handling of discordant negative human epidermal growth factor receptor 2 classification by Oncotype DX in patients with breast cancerMatthias Christgen, Nadia Harbeck, Oleg Gluz, et al.
Human Pathology|July 25, 2015
The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancerMatthias Christgen, Sabrina von Ahsen, Henriette Christgen, et al.
Cancer Letters|November 29, 2011
ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cellsTill Krech, Elisa Scheuerer, Robert Geffers, et al.
Plos One|September 12, 2013
Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?Inga Karch, Elisa Schipper, Henriette Christgen, et al.
Mathematical Biosciences|December 18, 2024
Deficient cell-cell cohesion is linked with lobular localization in simplified models of lobular carcinoma in situ (LCIS)Matthias Christgen, Rodrigo A Caetano, Michael Eisenburger, et al.
Genes, Chromosomes & Cancer|September 6, 2023
Frequency of genetic alterations differs in advanced breast cancer between metastatic sitesIsabel Grote, Alexandra Poppe, Ulrich Lehmann, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
BMC Biotechnology|November 29, 2008
Reliable microRNA profiling in routinely processed formalin-fixed paraffin-embedded breast cancer specimens using fluorescence labelled bead technologyBritta Hasemeier, Matthias Christgen, Hans Kreipe, et al.
International Journal of Cancer|March 15, 2021
Transcription factor AP-2beta in development, differentiation and tumorigenesisMieke Raap, Lisa Gierendt, Hans H Kreipe, et al.
Cancer Letters|August 23, 2005
Gemcitabine-mediated apoptosis is associated with increased CD95 surface expression but is not inhibited by DN-FADD in Colo357 pancreatic cancer cellsMatthias Christgen, Bodo Schniewind, Astrid Jueschke, et al.
Pathology, Research and Practice|January 26, 2024
Malignant phyllodes tumor and invasive lobular breast carcinoma: Morpho-molecular characterization of an uncommon collision tumor and review of the literatureNora Schaumann, Stephan Bartels, Elna Kuehnle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2012
Recognition and handling of discordant negative human epidermal growth factor receptor 2 classification by Oncotype DX in patients with breast cancerMatthias Christgen, Nadia Harbeck, Oleg Gluz, et al.
Human Pathology|July 25, 2015
The region-of-interest size impacts on Ki67 quantification by computer-assisted image analysis in breast cancerMatthias Christgen, Sabrina von Ahsen, Henriette Christgen, et al.
Cancer Letters|November 29, 2011
ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cellsTill Krech, Elisa Scheuerer, Robert Geffers, et al.
Plos One|September 12, 2013
Is upregulation of BCL2 a determinant of tumor development driven by inactivation of CDH1/E-cadherin?Inga Karch, Elisa Schipper, Henriette Christgen, et al.
Mathematical Biosciences|December 18, 2024
Deficient cell-cell cohesion is linked with lobular localization in simplified models of lobular carcinoma in situ (LCIS)Matthias Christgen, Rodrigo A Caetano, Michael Eisenburger, et al.
Genes, Chromosomes & Cancer|September 6, 2023
Frequency of genetic alterations differs in advanced breast cancer between metastatic sitesIsabel Grote, Alexandra Poppe, Ulrich Lehmann, et al.
Pageof 11